A practical guide written for family doctors by five clinicians.
What it found. Sulfonylureas and insulin usually need to be reduced or stopped when a patient cuts carbs, because blood glucose typically falls substantially. SGLT2 inhibitors carry a risk of ketoacidosis that can occur with normal blood glucose. Metformin, GLP-1 drugs and DPP-4 inhibitors pose no excess risk, and blood pressure medication may need adjusting too.
The limits. It is guidance for prescribers, based on clinical experience and how the drugs work, not a trial. It is not a set of instructions for patients.
An expert panel convened by the American Diabetes Association, reviewing the nutrition research for adults with diabetes.
What it found. Reducing overall carbohydrate intake has the most evidence for improving blood glucose. For select adults with type 2 diabetes, low- or very-low-carbohydrate eating plans are a viable approach, and they have been shown to reduce A1C and the need for glucose-lowering medication.
The limits. It supports several eating patterns, not one, and says the choice should fit the person. It found no qualifying trials of these patterns in adults with type 1 diabetes.
A pooled analysis of 23 randomized trials (1,357 people with type 2 diabetes) of low- and very-low-carbohydrate diets lasting at least 12 weeks.
What it found. At six months, 57% of people on low-carb diets had an HbA1c below 6.5%, against 31% on comparison diets, with large improvements in weight, triglycerides and insulin sensitivity.
The limits. The advantage was smaller when remission meant being off medication, was much weaker in studies that included people on insulin, and had largely faded by 12 months, when there were also signs of worse LDL cholesterol. Very-low-carb diets did well only among people who stuck to them.